Elizabeth Holmes’ Defense Rests Their Case in Fraud Trial

When asked how that had affected her work at Theranos, Ms. Holmes said it was difficult to separate where his influence began and ended. In legal filings before the trial, Mr. Balwani strongly denied allegations of abuse.

But Ms. Holmes also acknowledged making mistakes. She said she regretted adding the logos of pharmaceutical companies to validation reports that she had sent out to investors, which led them to believe that the drug companies had endorsed Theranos’s technology. She said she also regretted the way she had handled a Wall Street Journal exposé with private investigators and legal attacks on former employees who had spoken to the journalist. And she said she had allowed incorrect information to be disseminated in a positive Fortune cover article about her.

Ms. Holmes concluded a portion of her testimony with a speech about her intentions in pitching Theranos to investors, patients and the press.

“I wanted to convey the impact,” she said. “I wanted to talk about what this company could do a year from now, five years from now, 10 years from now. They weren’t interested in today or tomorrow or next month — they were interested in what kind of change we could make.”

It was all meant to support the defense’s main argument, as outlined in opening statements in September. Ms. Holmes, her lawyers said, made mistakes. But her mistakes were not a crime. She was naïve and ambitious, they argued, but never meant to deceive.

“Theranos didn’t see mistakes as crimes. They saw them as part of the path to success,” Lance Wade, one of Ms. Holmes’s lawyers, said in his opening statement.

In their cross-examination, prosecutors sought to dismantle Ms. Holmes’s excuses. They noted that Theranos had shared plenty of other trade secrets with its partners, which signed nondisclosure agreements. Mr. Leach pointed out times when Ms. Holmes allowed false or misleading information about Theranos to spread to investors and patients.

Earlier in the trial, during testimony from 29 witnesses called by prosecutors, Ms. Holmes’s lawyers sought to poke holes and create confusion around the facts of the case. They attacked the credibility of investors, trying to show that they should have done better research on Theranos before investing to understand the risks and the details of its business. And they tried to argue that patients who testified that they had received troubling blood test results from Theranos were not qualified to interpret them.

Erin Woo contributed reporting.

AI App Rolls Out www.aiapp.org: Your Single Source for the Foremost Language and Image Synthesis Models

[London, 13 Feb 2024] – AI App is proud to announce the launch of www.aiapp.org, a revolutionary platform that consolidates top-tier Large Language Models (LLMs) and text-to-image models under a single membership. This platform is meticulously designed to provide seamless access to a wide array of advanced AI models, including GPT-4, Google’s Gemini and PaLM […]

Know More

Niche SaaS company wins big with TurboTax $10.5 million dollar Super Bowl ad

By Alex Abagnale Robinson The Super Bowl was last night… it’s Monday morning… and like most people the first thing I do is open up my phone… “What did I miss?” As I’m aimlessly scrolling for the most recent Travis Kelsey and Taylor Swift sighting while my coffee brews… I see an interesting post on […]

Know More

From Code to Compassion: AI’s Journey in Deradicalizing Minds

Some people spend a lifetime trying to figure out what they’ve put on this planet to do. Very few people end up meeting the world’s most dangerous terrorist. By Mohammed Abbasi, Co-Director, Association of British Muslims. Website URL: www.mmabbasi.comTwitter: @MohammedAbbasiEmail: mohammed.abbasi@aobm.org When I first saw the email, I visualised I was going to fly to […]

Know More